AUT tech start-up develops breakthrough
RespirAq, an AUT tech spinout, has recently been granted breakthrough device designation from the U.S. Food and Drug Administration (FDA) for its Active Humidifier product*.
AUT Ventures launched RespirAq in late 2021, along with its founder and CEO, Dr Sandra Grau-Bartual, who was an AUT PhD student in the Faculty of Design and Creative Technologies, based in AUT’s Institute of Biomedical Technologies (IBTec).
Steve Corbett, CEO of AUT Ventures says, “This type of recognition by the FDA is very rare and a testament to Sandra and her team at RespirAq who have made incredible progress since they spun out in late 2021.
Keep up to date
See more news from the AUT Women in Tech team to stay in the loop with what's going on.